Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

48.34 +0.36 (+0.75%)
Streaming Delayed Price Updated: 11:30 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi-Aventis S.A. ADR

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). 
Via Benzinga
Heart Failure Treatment Offers Hope to Diabetics
Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart... 
Via FinancialNewsMedia
Why Kymera Therapeutics Shares Are Falling Today
Via Benzinga
Dupixent, Consumer Healthcare Lifts Sanofi's Q1 Earnings, Backs FY22 Guidance
Via Benzinga
Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
Dupixent sales rocketed higher in the quarter, driven by continued uptake in eczema treatment. 
Via Investor's Business Daily
7 Biotech Stocks With Key Catalysts for May
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
Via InvestorPlace
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings. 
Via Investor's Business Daily
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. 
Via Benzinga
Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers
Microsoft Corporation (NASDAQ: MSFT) CEO Satya Nadella said Tuesday that more than 10 million people have streamed games on its Xbox Cloud Gaming platform. What Happened: Nadella... 
Via Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a... 
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
Terran Biosciences is slowly but surely finding its place in the psychedelics industry. 
Via Benzinga
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
Via Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns. 
Via InvestorPlace
How To Attend Sanofi Q1 2022 Earnings Conference Call
Sanofi (NASDAQ:SNY) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a... 
Via Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
Via Benzinga
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent... 
Via FinancialNewsMedia
Exposures COVID-19
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Friday Stocks Update
Royal Dutch Shell rose again on its earnings but is still at a p/e ratio of under 11x earnings. 
Via Talk Markets
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... 
Via Benzinga
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier. 
Via Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
The  
Via Benzinga
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
Via Benzinga
Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May
Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business. 
Via Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.  
Via Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.